Aclarion, Inc.
Research Aclarion, Inc. (IT20) on Bullrun: market cap EUR 6.00M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIT20
- ExchangeF
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyEUR
- Market capEUR 6.00M
- Financial periodQ1 2026
- RevenueUSD 21.14K
- Net income-USD 2.85M
- Free cash flow-USD 2.69M
- Gross margin17.7%
Valuation Snapshot
latest market cap is EUR 6.00M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 75.73K | -USD 7.23M | -USD 7.37M | 9.0% | n/a | USD 12.02M | n/a | USD 12.84M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 6.00M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Aclarion, Inc.
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aclarion, Inc.'s market cap?
Aclarion, Inc.'s market capitalization is EUR 6.00M.
What does Aclarion, Inc. do?
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine.